ALICANTE VACCINES | Council approves purchase of 500,000 doses of pneumococcal vaccines
![ALICANTE VACCINES | Council approves purchase of 500,000 doses of pneumococcal vaccines ALICANTE VACCINES | Council approves purchase of 500,000 doses of pneumococcal vaccines](https://estaticos-cdn.prensaiberica.es/clip/93350bcd-04d9-4021-99ed-827614a552a8_16-9-aspect-ratio_default_0.jpg)
He Advice allowed processing contract for the purchase and supply of vaccines against pneumococcus, intended for the development of the immunization campaign of the Ministry of Health.
In particular, they will acquire 500,000 doses of pneumococcal vaccine to ensure vaccination of the child population, as well as the adult population and risk groups for whom it is indicated.
The vaccine that needs to be purchased is conjugate of 20 serotypes, which will replace after the contract is signed A 13-serotype conjugate vaccine that is currently being administered. in the first year of life. These seven vaccine serotypes will significantly increase the security of the child population.
Pneumonia
Over the past five years pneumonia was the most common manifestation of invasive pneumococcal disease (IPD) in children under 5 years of age, accounting for 41.2% of cases, followed by sepsis (24%) They created more than 700 hospitalizations with an average length of stay of 7.11 days, According to the Generalitat.
Similarly,in persons over 65 years of age, The most common manifestation of this pathology was pneumonia, accounting for 52.8% of cases. In addition, most cases (94.2%) required hospitalization with an average duration of 12.2 days.
Dissatisfaction among patients invited to Alicante for pneumococcal vaccination due to lack of doses
Specified groups
In this sense, the specified groups are people from 18 to 64 years of age with certain risk factors, healthy people in the first year of life and 65 years and older, elderly population of residential buildings.
The estimated cost of a contract consisting of one lot is The project costs 47.9 million euros and will last for two years.with the possibility of extension for another two years.
Doses of these vaccines will be distributed in Medical centers Ministry of Health to develop vaccination campaigns after the contract is formalized.
This immunization is intended for people shield against bacteria that cause pneumococcal disease, A severe bacterial infection caused by Streptococcus pneumoniae. These bacteria can also cause pneumonia, meningitis or bloodstream infection (bacteremia).
Three doses
Vaccination recommendations agreed in Interterritorial Council of the National Health System, formed by the Ministry of Health and the autonomous communities, include administration of three doses of conjugate vaccine at 2, 4 and 11 months, i.e. in the first year of life; and vaccination from 65 years old. The province of Alicante has more than 390,000 people in this age group. It is also indicated for risk groups.